Camlin Fine Sciences to raise Rs 1,800 million from funds advised by Convergent Finance LLP

26 Jun 2020 Evaluate

Camlin Fine Sciences’ (CFS) board has considered and approved the raising of funds of upto Rs 1,800 million ($23.8 million) from Infinity Holdings and its affiliated entities, with Convergent Finance LLP (Convergent) acting as an investment advisor. Structured as a subscription to equity warrants priced based on the prevailing market price and in accordance with applicable SEBI regulations, the investment will result in an approximately 22.65% ownership stake on a fully diluted basis.

The purpose of fund raise would be to consolidate and acquire the entire stake of its joint venture partners in the company's subsidiaries in Mexico and China, i.e. Dresen Quimica S.A.P.l. de C.V and CFS Wanglong Flavours Ningbo Co., as well as to enhance the company's portfolio in Heath & Wellness segment by launching new products.

Camlin Fine Sciences is the world's second largest manufacturer and marketer of food grade antioxidants BHA (butylated hydroxyanisole) and TBHQ (Tertiary Butylhydroquinone).

Camlin Fine Sciences Share Price

119.95 0.80 (0.67%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Tata Chemicals 1069.40
SRF 2165.85
Pidilite Inds. 2958.60
Aarti Inds 430.80
Atul 7261.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.